AI assistant
Chemomab Therapeutics Ltd. — Director's Dealing 2021
Mar 25, 2021
35107_dirs_2021-03-25_90a308c0-b233-477c-9d26-437908f8f9bc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Chemomab Therapeutics Ltd. (CMMB)
CIK: 0001534248
Period of Report: 2021-03-16
Reporting Person: SQUINTO STEPHEN P (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| American Depositary Shares | 47938 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option to purchase American Depositary Shares | $0.67 | 2025-11-18 | American Depositary Shares (424) | Direct | |
| Option to purchase American Depositary Shares | $0.80 | 2026-09-13 | American Depositary Shares (2109) | Direct | |
| Option to purchase American Depositary Shares | $1.49 | 2027-11-19 | American Depositary Shares (21095) | Direct | |
| Option to purchase American Depositary Shares | $1.49 | 2028-10-21 | American Depositary Shares (32928) | Direct | |
| Option to purchase American Depositary Shares | $1.48 | 2030-11-19 | American Depositary Shares (40362) | Direct |
Footnotes
F1: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
F2: These options have vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service.
F3: 14,059 of these options to purchase ADSs have vested and are exercisable as of the date hereof, while the remaining 7,036 of these options will vest and become exercisable in three installments, with 1/3 of the options vesting on each three month anniversary commencing on May 16, 2021, subject to the Reporting Person's continued service.
F4: 5,042 of these options to purchase ADSs have vested and are exercisable as of the date hereof, while the remaining 35,320 of these options will vest and become exercisable in seven installments, with 1/7 of the options vesting on each three month anniversary commencing on May 19, 2021, subject to the Reporting Person's continued service.